Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
News|Slideshows|March 7, 2025
AAD 2025: Atopic Dermatitis Preview
Author(s)Sydney Jennings
Fact checked by: Grace Halsey
Preview the posters and abstracts covering atopic dermatitis advances from Arcutis, Incyte, Lilly and Sanofi/Regeneron.
Advertisement
The American Academy of Dermatology 2025 (AAD) Conference kicks off in earnest March 7 in Orlando, Florida. This year's show is overflowing with new insights on treatments in development for a host of conditions, including atopic dermatitis.
Check out the slideshow above for a preview of some of the research set to presented at AAD 2025, and be sure to visit our
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
Advertisement
Advertisement
Trending on Patient Care Online
1
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
2
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
3
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
4
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
5